Efficacy and Safety of Abatacept, Adalimumab, and Etanercept in Pediatric Patients With Juvenile Idiopathic Arthritis

OBJECTIVE: The lack of randomized controlled trials comparing biologics for the treatment of juvenile idiopathic arthritis (JIA) has led to wide variation in treatment approaches. The objective of this study is to compare the efficacy and safety of abatacept, adalimumab, and etanercept in JIA patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pediatr Pharmacol Ther
Main Authors: Goettel, Andrea M., DeClercq, Josh, Choi, Leena, Graham, Thomas B., Mitchell, Amy A.
Formato: Artigo
Idioma:Inglês
Publicado em: Pediatric Pharmacy Advocacy Group 2021
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887882/
https://ncbi.nlm.nih.gov/pubmed/33603579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-26.2.157
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados